Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Waltermire Robert E. | MDGL | Senior VP, Chief Pharma Dev. | Mar 5 '25 | Sell | $340.42 | 14,113 | $4,817,103.60 | 16,941 |